1318792-82-3

Upstream product

• 1318792-81-2 tert-butyl N-[3-(4-bromophenyl)propyl]-N-(3-methoxypropyl)carbamate 
• 73183-34-3 bis(pinacol)diborane 
• 25574-11-2 3-(4-bromophenyl)propanol 
• 1643-30-7 3-(4-bromophenyl)propionic acid 
• 165803-63-4 3-(4-bromophenyl)propyl methanesulfonate 
• 1318792-80-1 3-(4-bromophenyl)-N-(3-methoxypropyl)propan-1-amine 

Downstream Products

• 1318792-84-5 tert-butyl N-[3-{4-[5-amino-6-(3-pyridylcarbamoyl)pyrazin-2-yl]phenyl}propyl]-N-(3-methoxypropyl)carbamate 
• 1318792-63-0 AZD₇₉₂₉ 
• 1318792-64-1 3-amino-6-(4-{3-[(3-methoxypropyl)amino]propyl}phenyl)-N-pyridin-3-ylpyrazine-2-carboxamide mono-besylate 
• 1318792-65-2 3-amino-6-(4-{3-[(3-methoxypropyl)amino]propyl}phenyl)-N-pyridin-3-ylpyrazine-2-carboxamide mono-tosylate 
• 1318792-68-5 3-amino-6-(4-{3-[(3-methoxypropyl)amino]propyl}phenyl)-N-pyridin-3-ylpyrazine-2-carboxamide mono-DL-mandelate 

Relevant academic research and scientific papers

PYRAZINE DERIVATIVES

The invention concerns pyrazine derivatives of the Formula (I) or pharmaceutically-acceptable salts thereof; wherein each of n, m and R has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of bone-related disorders or conditions